Citigroup Inc. Purchases 18,525 Shares of Masimo Corporation (MASI)
Citigroup Inc. boosted its position in Masimo Corporation (NASDAQ:MASI) by 218.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 27,015 shares of the medical equipment provider’s stock after purchasing an additional 18,525 shares during the quarter. Citigroup Inc. owned about 0.05% of Masimo Corporation worth $2,463,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Fortaleza Asset Management Inc. bought a new stake in Masimo Corporation in the 2nd quarter valued at $106,000. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in Masimo Corporation by 32.2% in the 1st quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 1,782 shares of the medical equipment provider’s stock valued at $166,000 after purchasing an additional 434 shares during the period. Dubuque Bank & Trust Co. boosted its stake in Masimo Corporation by 3.4% in the 2nd quarter. Dubuque Bank & Trust Co. now owns 1,869 shares of the medical equipment provider’s stock valued at $170,000 after purchasing an additional 61 shares during the period. Neuberger Berman Group LLC bought a new stake in Masimo Corporation in the 1st quarter valued at $206,000. Finally, Campbell & CO Investment Adviser LLC bought a new stake in Masimo Corporation in the 2nd quarter valued at $203,000. Institutional investors and hedge funds own 83.21% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Citigroup Inc. Purchases 18,525 Shares of Masimo Corporation (MASI)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright law. The original version of this story can be read at https://www.thecerbatgem.com/2017/09/28/citigroup-inc-purchases-18525-shares-of-masimo-corporation-masi.html.
Several research firms recently issued reports on MASI. Zacks Investment Research downgraded Masimo Corporation from a “hold” rating to a “sell” rating in a research note on Tuesday, July 4th. BidaskClub downgraded Masimo Corporation from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Roth Capital boosted their price target on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a research note on Wednesday, July 19th. BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price objective for the company in a report on Monday, August 14th. Finally, Stifel Nicolaus began coverage on Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 price objective for the company. One research analyst has rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the stock. Masimo Corporation currently has an average rating of “Hold” and a consensus target price of $95.00.
Masimo Corporation (NASDAQ:MASI) opened at 85.63 on Thursday. The firm has a 50-day moving average price of $85.78 and a 200 day moving average price of $90.95. Masimo Corporation has a one year low of $53.78 and a one year high of $104.71. The firm has a market capitalization of $4.45 billion, a PE ratio of 14.04 and a beta of 0.84.
Masimo Corporation (NASDAQ:MASI) last posted its quarterly earnings results on Wednesday, August 2nd. The medical equipment provider reported $0.83 EPS for the quarter, topping the Zacks’ consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The firm had revenue of $192.90 million during the quarter, compared to analyst estimates of $189.03 million. During the same period last year, the company earned $0.57 earnings per share. The business’s revenue for the quarter was up 11.8% on a year-over-year basis. Analysts anticipate that Masimo Corporation will post $2.80 EPS for the current fiscal year.
In related news, insider Jon Coleman sold 25,000 shares of Masimo Corporation stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $97.50, for a total transaction of $2,437,500.00. Following the completion of the sale, the insider now owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Sanford Fitch sold 11,000 shares of Masimo Corporation stock in a transaction on Thursday, August 17th. The shares were sold at an average price of $87.25, for a total value of $959,750.00. Following the sale, the director now directly owns 72,249 shares of the company’s stock, valued at approximately $6,303,725.25. The disclosure for this sale can be found here. Insiders sold 112,000 shares of company stock valued at $10,444,090 over the last ninety days. Corporate insiders own 16.60% of the company’s stock.
Masimo Corporation Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Stock Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related stocks with our FREE daily email newsletter.